Soteropoulos Paula
SEC insider (Form 3/4/5 filer). CIK 0001692444. Director at Rallybio Corp (RLYB) and 1 other issuer. 10 reported Form 4/5 transactions since Sep 2024; latest on Oct 16, 2026. Located in EAST BERLIN, CT.
Companies Soteropoulos Paula has filed insider reports for
- Rallybio Corp (RLYB): Director
- Dianthus Therapeutics, Inc. /DE/ (DNTH): Director
Soteropoulos Paula
CIK: 0001692444
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Oct 16, 2026RLYB
Rallybio Corp
ExerciseDirect3.6K shares at avg. $2.38$8K - May 21, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
AwardDirectStock Option (Right to Buy)
6.1K shares- - May 8, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
SaleDirect599 shares at avg. $85.47$51K - May 8, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
ExerciseDirect599 shares at avg. $8.44$5K - Mar 31, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
ExerciseDirect599 shares at avg. $8.44$5K - Mar 31, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
SaleDirect599 shares at avg. $80.11$48K - Mar 24, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
ExerciseDirect27.6K shares at avg. $8.44$233K - Mar 24, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
SaleDirect27.6K shares at avg. $78.05$2.2M - May 22, 2025DNTH
Dianthus Therapeutics, Inc. /DE/
AwardDirectStock Option (Right to Buy)
12.5K shares- - May 13, 2025RLYB
Rallybio Corp
AwardDirectOption (Right to Buy)
28.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 16, 2026 |  RLYB Rallybio Corp | Exercise | 3,562 | $2.38 | $8,478 | Direct |
| May 21, 2026 |  DNTH Dianthus Therapeutics, Inc. /DE/ | Award Stock Option (Right to Buy) | 6,090 | - | - | Direct |
| May 8, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | 599 | $85.47 | $51,197 | Direct |
| May 8, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Exercise | 599 | $8.44 | $5,056 | Direct |
| Mar 31, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Exercise | 599 | $8.44 | $5,056 | Direct |
| Mar 31, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | 599 | $80.11 | $47,986 | Direct |
| Mar 24, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Exercise | 27,594 | $8.44 | $232,893 | Direct |
| Mar 24, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | 27,594 | $78.05 | $2,153,712 | Direct |
| May 22, 2025 | DNTH Dianthus Therapeutics, Inc. /DE/ | Award Stock Option (Right to Buy) | 12,500 | - | - | Direct |
| May 13, 2025 | RLYB Rallybio Corp | Award Option (Right to Buy) | 28,500 | - | - | Direct |
1-10 of 10 transactions